3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
152
Lymphoma, Mantle-Cell
30
Lymphoma, Non-Hodgkin
22
Lymphoma, Follicular
22
Lymphoma
22
Recurrence
21
Neoplasms, Plasma Cell
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myeloid, Acute
12
Waldenstrom Macroglobulinemia
11
Lymphoma, Large B-Cell, Diffuse
11
Immunoglobulin Light-chain Amyloidosis
10
Neoplasms
8
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma, B-Cell
7
Leukemia
6
Carcinoma, Non-Small-Cell Lung
6
Myelodysplastic Syndromes
5
Hematologic Neoplasms
5
Brain Neoplasms
5
Amyloidosis
5
Lymphoma, Large-Cell, Immunoblastic
4
Hematologic Diseases
4
Congenital Abnormalities
4
Prostatic Neoplasms
3
Paraproteinemias
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Monocytic, Acute
3
Leukemia, Erythroblastic, Acute
3
Interventions
fluciclovine F-18
2
Positron-Emission Tomography
2
Injections
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
pembrolizumab
1
ioflupane
1
idelalisib
1
aflibercept
1
Water
1
Vertical Dimension
1
Methylene Blue
1
Mammography
1
Drug Delivery Systems
1
Diagnosis, Computer-Assisted
1
Daunorubicin
1
Cytarabine
1
Control Groups
1
CPX-351
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Disease
×
Bortezomib
×
Clear all
No trials found.